301

=24010203040506070ACAMPA(ABPM)J-MORE(HBPM)(SBP/DBP

-20(mmHg) A B Neutel JM, Blood Pressure Monitoring 2001, 6: 9-16-15-10-50

10-20%(20%)(10%)()Prev Cardiol.2007;10(4):210-4. BP(mmHg)135/85120/75/

J Cardiovasc Pharmacol.2003;41 Suppl 1:S61-6.(%)SCI(%)5435(65%)7(13%)12(22%)(n=64)(n=153)(n=111)(n=33)(n=97)(n=230)(n=185)(n=63)P=0.01P=0.001P=0.03P=0.055P=0.0001P=0.00212141414SCI

6:00-11:59135/85mmHg140/90mmHgFamily Practice. 2011;0:1-6.doi:10.1093/fampra/cmr121.J Clin Hypertens (Greenwich). 2007;9(3):224-8.

NT: M-HT: E-HT: S-HT:Hypertension.2006;48(4):737-43.

P0.0001P=0.027P=0.002P=0.470IMT(r)(OR)CIMT0.80mmHypertens Res.2004;27(9):633-9.

Chart1

0.422

0.021

1

Sheet1

1

0.422

0.021

Chart1

6.3

1.5

1

Sheet1

1

6.3

1.5

Family Practice. 2011;0:1-6.doi:10.1093/fampra/cmr121.P

LVM / h(g/m2,7)SBPJ Hypertens. 2004 Jun;22(6):1113-8.LVHSBP50724h

Chart1

47

49

51

53

*

*

*

* p

2*19(%)7.3n=53n=466Kario K, et al. Circulation. 2003;107(10):1401-6.2.7(P=0.04)

5194124h

Chart1

19

7.3

2

Sheet1

2

19

7.3

SBP -10 mm HgDBP -5 mm Hg ..,2009,27(5):1110-1112Lancet, 2002, 360 (9349) : 1903 - 1913.

2002Lewington S.6

Chart1

-40

-30

1

Sheet1

1 2 3

-402.42

-304.42

33.51.83

44.52.85

=24

%1979-2002

>60

75%60% Patients6049%2601

Chart1

Below 4010

1015

2575

Total100

75

Sheet1

Below 404060Above 60Total

1025

101575100

2010

24h

2008

641spaceLab24 h2 h 01020304050

2010. ,2011;39(7):579-616.1/d24h

24

135/85mmHg

24

Hypertension 2010;56:765-773.

Blood Press Monit.2011;16(2):80-6.(mmHg)24()

24hInt Heart J.2005;46(3):433-42.(SBP1, DBP1)(SBP2, DBP2)CCB424SBP1SBP2DBP1DBP2()(mmHg)

6.6mmHg8.4mmHgHypertens Res 2004;27:15-20.(mmHg)n=1624 P0.0524 (mmHg)n=14P0.01P0.05P0.01P0.01P0.053.96.6118.4

24 4Ole Lederballe Pedersen, et al. Journal of Hypertension 2007, 25:7077121 6 11 1621 24()210-1-2-3-4(mmHg) * P=0.0302.7mmHg4 VALUE659VALUE(n=327)(n=332)25201

24Ferrucci A, et al. Clin. Drug Invest. 1997;13(Suppl 1):67-7224h 40(5 mg / n=20) (30mg/n=20)12 24h 1224

NORVASC US PI.24h

Mims Annual 1994. Kaiser G et al. 1990,Ulm Eh et al, 1982, Salveth A, 1990

()()(%)6-1235-5064-906-121.7-3.431-482.5-511-1620

20121994SFDA

24

*24ACAMPAJ-MOREACAMPA29022450% 135/85 mmHg 262%J-MORE96961%< 140/90 mmHg 135/85 mmHg

**AB20084:008:0055mmHg24h2.7****24405-10mg30-60mg2424*